MRNA Stock Plunges 18% After Leaked Melanoma Vaccine Data Misses High Hopes

Investors were awaiting full data from the late-stage trial of intismeran autogene plus Merck’s Keytruda at the European Society for Medical Oncology Congress on October 24.
Read the full report on Asianet Newsable
Story file
- Section
- Health
- Topics
- Stock market, Health alerts
- First reported by
- Asianet Newsable
- Reporter
- stocktwits inc
- Published
- Friday, 23 October 2026, 3:00 am IST
- Coverage
- One outlet so far
How this page works. The Headline Update lists this report from Asianet Newsable with a short summary and a link to the original. The original reporting and photograph belong to the publisher. Spotted an error in our summary? Tell our corrections desk.
